Research / LEDS / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-21-058603 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
162.15% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.49% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-36.68% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-21.97% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
83.15% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
21.82% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-82.75% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
34.28% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.93% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Aug 31, 2021 0/9 normalized Level 3 Nov 30, 2021 0/9 normalized Level 3 Feb 28, 2022 0/9 normalized Level 3 May 31, 2022 8/9 normalized Level 3 Aug 31, 2022 8/9 normalized Level 3 Nov 30, 2022 8/9 normalized Level 3 Feb 28, 2023 8/9 normalized Level 3 May 31, 2023 9/9 normalized Level 3 Aug 31, 2023 9/9 normalized Level 3 Nov 30, 2023 9/9 normalized Level 3 Feb 29, 2024 9/9 normalized Level 3 May 31, 2024 9/9 normalized Level 3 Aug 31, 2024 9/9 normalized Level 3 Nov 30, 2024 9/9 normalized Level 3 Feb 28, 2025 9/9 normalized Level 3 May 31, 2025 9/9 normalized Level 3 Aug 31, 2025 9/9 normalized Level 3 Nov 30, 2025 9/9 normalized Level 3 Feb 28, 2026 9/9 normalized Level 3 May 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 544.48%
Current 162.15%
Delta -382.32% Capex Intensity Increased
Previous 0.97%
Current 2.49%
Delta 1.52% Cash Generation Decreased
Previous -13.97%
Current -36.68%
Delta -22.72% Growth Decreased
Previous -8.29%
Current -21.97%
Delta -13.68% Inventory Pressure Decreased
Previous 251.42%
Current 83.15%
Delta -168.28% Margin Decreased
Previous 46.14%
Current 21.82%
Delta -24.33% Profitability Decreased
Previous -41.14%
Current -82.75%
Delta -41.61% R And D Intensity Decreased
Previous 36.69%
Current 34.28%
Delta -2.42% Sbc Intensity Increased
Previous 3.34%
Current 3.93%
Delta 0.59% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.